Rheumnow

  - QD221: RA & Vaccination  (Dr. J. Cush) https://youtu.be/6qsz0TPVKLU   - QD222: Goal of the First Visit (Dr. J Cush)  https://youtu.be/EwsO9LCywzI   - QD223: MTX Pearls  (Dr. J Cush) https://youtu.be/fktKlc0Pk-o   - QD224: RA on MTX with Progressive Dyspnea (Dr. R. Conway)  https://youtu.be/g1Q_uG9zZ0g

- Hard Decisions - Debate: Triple DMARD Therapy (Drs. Pope & Wells) https://youtu.be/22NDkYnIUS0 - Hard Decisions: Perspectives: The Future of RA  (Drs. McInnes & Burmester)  https://youtu.be/HoxrZk5FG14 - Hard Decisions - Perspectives: Steroid Use in RA (Drs. Landewe, England, Nash)   https://youtu.be/tcX8GA6xzQw - Hard Decisions: HSV and RSV Update for Rheumatology  (Dr. Winthrop) https://youtu.be/TZVcZW4DvQo

- Hard Decisions Debate: Imaging in RA (Drs. Troum & Ruderman)  https://youtu.be/mFDZRmhPOPk- Hard Decisions: Import of Seropositivity (Dr. Cush) https://youtu.be/jePnI49K2u4 - Hard Decisions: MTX Dosing and Monitoring Issues (Dr. Weinblatt)  https://youtu.be/XKAFe-xMkyU - Hard Decisons - Perspectives: Difficult to Treat RA (Drs. Kavanaugh & Cush)  https://youtu.be/Lmc6u9wFJU8

This week, Dr. Jack Cush reviews the news with special guest, Dr. Peter Nash. They discuss COVID Autoantibodies, SpA life expectancy, HCQ, extraarticular RA and our approach to Early RA referrals and pre-clinical RA.

This Tuesday Night Rheumatology was an hour long panel discussion  featuring Drs. Jack Cush, Vivian Bykerk, Glenn Hazelwood and Martin J. Bergman. The Panel discussed Rheumatologists views on Early RA referral and intake, initial treatment preferences and views on diagnosing and treating pre-clinical RA.  Recorded on 9/12/2023

This week, Dr. Jack Cush reviews the news with special guest, Dr. Janet Pope. They discuss "Not-non-Inferior", large scale genetic screening, Zoster risk w/ newer lupus drugs, Tapering, RA referral problems and the TNR webinar session on "Oral Surveillance Revisited"

This Tuesday Nite Rheumatology was an hour long panel discussion featuring Drs. Janet Pope, Jeff Curtis, Jon Giles and Roy Fleischmann. They reviewed the results and interpretations of the Oral Surveillance Study, Rheumatologists responses to a survey on this study and fielded questions from a Rheumatologist audience. Recorded 9/5/23.

Rheumatologists Dr. Roy Fleischmann and Dr. Janet Pope discuss treatment options for patients with RA who have failed a TNFi. The experts consider switching to an alternate MOA vs cycling to another TNFi.

Dr. Jack Cush Reviews the news and journal reports from this past week on RheumNow; and introduces September campaign - "Hard Decisions in RA".

Dr. Jack Cush comments on the news and journal articles from the past week on RheumNow.com. This VEXAS scoring, scleroderma sine scleroderma and head scratchers from southeast Asia.

Dr. Jack Cush reviews the news and journal reports from RheumNow.com this past week.

Dr. Jack Cush reviews the news and journal reports from the wonderful wide world of Rheumatology.

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  This week highlights Veterans, Vegetarians and Antenatal Corticosteroids.

Listen as rheumatologists Dr. Philip Mease and Dr. Saakshi Khattri share their insights on using composite measures to manage patients with psoriatic arthritis. In this podcast, they discuss four composite measures used in trials of an IL-23 inhibitor.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.  This week COVID persists, mortality stems from misdiagnosis, and cervical pain is more than a pain in the neck.

Dr. Jack Cush reviews the news and journal reports and this week, takes on 5 cases/questions from "Ask Cush Anything"

Dr. Jack Cush Reviews the news and journal reports on CVA, TKA, PJP, ADA, and more!

Dr. Jack Cush Reviews the news, journal articles and regulatory decisions from the past week from RheumNow.com. This week focuses on parodoxical psoriasis, scleroderma outcomes and subsets, and alopecia areata therapy.

Dr. Jack Cush reviews the news and reports from the past week on RheumNow.com. This week a new colchicine FDA approval, rising rate of IgG4 related disease and what's the safest biologic?

Effect of Ancestry on Therapeutic Outcomes in SLE  Dr. Yuz Yusof   https://youtu.be/QqthOjDxePE De Novo Renal Nephritis Flares During Belimumab Trials  Drs. Yuz Yusof and Iaonnis Parodis   https://youtu.be/BYORFgYOdcI Update on CAR T Cell Therapy in SLE & Autoimmune Diseases  Dr. Peter Nash   https://youtu.be/KnHRgaEcqGc  We should put the CART before the T in SLE!  Dr. Janet Pope  https://youtu.be/carHG-5mFmQ Changes in the Causes and Predictors of Lupus Mortality in Spain  Dr. Bella Mehta  https://youtu.be/Yzm4twLAWfI JAK/TYK Inhibitors in SLE  Dr. Janet Pope   https://youtu.be/3wy5pOpbyPY Upadacitinib in SLE  Dr. Peter Nash    https://youtu.be/eqnXUrgpWdM SLE Trial: Dual BTK JAK Blockade compared Upadacitinib Monotherapy Dr. Yuz Yusof   https://youtu.be/yTmQTA7yU8U Efficacy and Safety of Baricitinib in Lupus Nephritis  Dr. Yuz Yusof  https://youtu.be/DgTIdAlhK_s Baricitinib in Lupus Nephritis  Dr. Peter Nash  https://youtu.be/qyhMHyYKuTU